Medical treatment for benign prostatic hyperplasia.
- 9 May 1992
- Vol. 304 (6836) , 1198-1199
- https://doi.org/10.1136/bmj.304.6836.1198
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Alfuzosin for treatment of benign prostatic hypertrophyThe Lancet, 1991
- Measurement of Prostate-Specific Antigen in Serum as a Screening Test for Prostate CancerNew England Journal of Medicine, 1991
- A Twelve-Week Placebo-Controlled Study of Prazosin in the Treatment of Prostatic ObstructionUrologia Internationalis, 1990
- Clinical Overview of Prazosin in the Treatment of Prostatic ObstructionUrologia Internationalis, 1990
- Characterisation of Human Prostatic Adrenoceptors using Pharmacology Receptor Binding and LocalisationBritish Journal of Urology, 1989
- Prazosin in the Treatment of Prostatic Obstruction A Placebo‐controlled StudyBritish Journal of Urology, 1987
- A Double‐blind Controlled Trial of a New α‐1 Blocking Drug in the Treatment of Bladder Outflow ObstructionBritish Journal of Urology, 1985
- A Placebo‐controlled Double‐blind Study of the Effect of Phenoxybenzamine in Benign Prostatic ObstructionBritish Journal of Urology, 1978
- Urinary incontinence caused by prazosin.BMJ, 1978
- Adrenergic and Cholinergic Receptors in the Human Prostate, Prostatic Capsule and Bladder NeckBritish Journal of Urology, 1975